Annual Total Expenses
$604.63 M
+$158.89 M+35.65%
September 30, 2024
Summary
- As of February 7, 2025, ARWR annual total expenses is $604.63 million, with the most recent change of +$158.89 million (+35.65%) on September 30, 2024.
- During the last 3 years, ARWR annual total expenses has risen by +$317.31 million (+110.44%).
- ARWR annual total expenses is now at all-time high.
Performance
ARWR Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$162.20 M
-$13.94 M-7.91%
September 30, 2024
Summary
- As of February 7, 2025, ARWR quarterly total expenses is $162.20 million, with the most recent change of -$13.94 million (-7.91%) on September 30, 2024.
- Over the past year, ARWR quarterly total expenses has increased by +$36.01 million (+28.54%).
- ARWR quarterly total expenses is now -7.91% below its all-time high of $176.14 million, reached on June 30, 2024.
Performance
ARWR Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
ARWR Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +35.6% | +28.5% |
| 3 y3 years | +110.4% | +57.2% |
| 5 y5 years | +461.9% | +57.2% |
ARWR Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +110.4% | -7.9% | +78.7% |
| 5 y | 5-year | at high | +461.9% | -7.9% | +372.8% |
| alltime | all time | at high | >+9999.0% | -7.9% | >+9999.0% |
Arrowhead Pharmaceuticals Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | $604.63 M(+35.6%) | $162.20 M(-7.9%) |
| Jun 2024 | - | $176.14 M(+39.6%) |
| Mar 2024 | - | $126.19 M(-9.9%) |
| Dec 2023 | - | $140.10 M(+12.6%) |
| Sep 2023 | $445.74 M(+5.7%) | $124.43 M(+5.0%) |
| Jun 2023 | - | $118.53 M(+20.8%) |
| Mar 2023 | - | $98.10 M(-6.3%) |
| Dec 2022 | - | $104.68 M(-9.3%) |
| Sep 2022 | $421.74 M(+46.8%) | $115.41 M(+9.6%) |
| Jun 2022 | - | $105.32 M(-4.5%) |
| Mar 2022 | - | $110.25 M(+21.5%) |
| Dec 2021 | - | $90.76 M(-12.0%) |
| Sep 2021 | $287.32 M(+58.6%) | $103.17 M(+32.7%) |
| Jun 2021 | - | $77.76 M(+27.4%) |
| Mar 2021 | - | $61.04 M(+34.6%) |
| Dec 2020 | - | $45.36 M(-21.5%) |
| Sep 2020 | $181.15 M(+68.3%) | $57.75 M(+33.3%) |
| Jun 2020 | - | $43.32 M(-5.3%) |
| Mar 2020 | - | $45.77 M(+33.4%) |
| Dec 2019 | - | $34.31 M(+1.9%) |
| Sep 2019 | $107.61 M(+49.3%) | $33.65 M(+39.6%) |
| Jun 2019 | - | $24.10 M(-7.8%) |
| Mar 2019 | - | $26.14 M(+10.2%) |
| Dec 2018 | - | $23.71 M(+5.7%) |
| Sep 2018 | $72.08 M(+5.4%) | $22.42 M(+34.7%) |
| Jun 2018 | - | $16.65 M(+6.1%) |
| Mar 2018 | - | $15.68 M(-9.5%) |
| Dec 2017 | - | $17.32 M(-8.7%) |
| Sep 2017 | $68.40 M(-14.3%) | $18.96 M(+26.0%) |
| Jun 2017 | - | $15.06 M(-0.4%) |
| Mar 2017 | - | $15.12 M(-21.5%) |
| Dec 2016 | - | $19.27 M(-2.6%) |
| Sep 2016 | $79.85 M(-17.1%) | $19.78 M(+2.0%) |
| Jun 2016 | - | $19.38 M(-9.0%) |
| Mar 2016 | - | $21.31 M(+9.9%) |
| Dec 2015 | - | $19.39 M(-23.3%) |
| Sep 2015 | $96.36 M(+87.9%) | $25.27 M(+56.8%) |
| Jun 2015 | - | $16.12 M(-45.7%) |
| Mar 2015 | - | $29.68 M(+17.4%) |
| Dec 2014 | - | $25.29 M(+25.0%) |
| Sep 2014 | $51.28 M(+117.5%) | $20.23 M(+58.7%) |
| Jun 2014 | - | $12.74 M(+13.2%) |
| Mar 2014 | - | $11.26 M(+59.6%) |
| Dec 2013 | - | $7.05 M(-12.3%) |
| Sep 2013 | $23.57 M(+11.0%) | $8.04 M(+56.9%) |
| Jun 2013 | - | $5.13 M(-5.7%) |
| Mar 2013 | - | $5.43 M(+9.4%) |
| Dec 2012 | - | $4.97 M(-8.4%) |
| Sep 2012 | $21.24 M | $5.42 M(-20.9%) |
| Jun 2012 | - | $6.85 M(+39.8%) |
| Mar 2012 | - | $4.90 M(+20.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | - | $4.06 M(+39.5%) |
| Sep 2011 | $10.13 M(+73.6%) | $2.91 M(+64.5%) |
| Jun 2011 | - | $1.77 M(-2.3%) |
| Mar 2011 | - | $1.81 M(-50.1%) |
| Dec 2010 | - | $3.63 M(+103.5%) |
| Sep 2010 | $5.83 M(-75.0%) | $1.79 M(+28.3%) |
| Jun 2010 | - | $1.39 M(-0.4%) |
| Mar 2010 | - | $1.40 M(-39.5%) |
| Dec 2009 | - | $2.31 M(-37.1%) |
| Sep 2009 | $23.32 M(-35.8%) | $3.67 M(-25.6%) |
| Jun 2009 | - | $4.94 M(-9.1%) |
| Mar 2009 | - | $5.43 M(-41.5%) |
| Dec 2008 | - | $9.28 M(-19.3%) |
| Sep 2008 | $36.31 M(-7.3%) | $11.50 M(+13.5%) |
| Jun 2008 | - | $10.13 M(+29.9%) |
| Mar 2008 | - | $7.80 M(+7.1%) |
| Dec 2007 | - | $7.29 M(-40.4%) |
| Sep 2007 | $39.16 M(+85.8%) | $12.22 M(-12.8%) |
| Jun 2007 | - | $14.02 M(+66.2%) |
| Mar 2007 | - | $8.44 M(+88.1%) |
| Dec 2006 | - | $4.48 M(-23.9%) |
| Sep 2006 | $21.08 M(+107.0%) | $5.89 M(+23.6%) |
| Jun 2006 | - | $4.77 M(-20.4%) |
| Mar 2006 | - | $5.99 M(+37.2%) |
| Dec 2005 | - | $4.37 M(+19.2%) |
| Sep 2005 | $10.18 M(+252.7%) | $3.66 M(+23.0%) |
| Jun 2005 | - | $2.98 M(+70.7%) |
| Mar 2005 | - | $1.75 M(-3.4%) |
| Dec 2004 | - | $1.81 M(+14.4%) |
| Sep 2004 | $2.89 M(+2958.4%) | $1.58 M(+149.4%) |
| Jun 2004 | - | $633.20 K(+19.1%) |
| Mar 2004 | - | $531.50 K(+273.0%) |
| Dec 2003 | - | $142.50 K(+850.0%) |
| Sep 2003 | $94.40 K(-93.3%) | $15.00 K(-2.0%) |
| Jun 2003 | - | $15.30 K(-49.5%) |
| Mar 2003 | - | $30.30 K(-10.4%) |
| Dec 2002 | - | $33.80 K(-97.4%) |
| Sep 2002 | $1.42 M(+1127.1%) | $1.32 M(+2587.0%) |
| Jun 2002 | - | $49.10 K(+113.5%) |
| Mar 2002 | - | $23.00 K(-15.1%) |
| Dec 2001 | - | $27.10 K(-11.4%) |
| Sep 2001 | $115.60 K(-13.8%) | $30.60 K(+62.8%) |
| Jun 2001 | - | $18.80 K(-26.6%) |
| Mar 2001 | - | $25.60 K(-36.9%) |
| Dec 2000 | - | $40.60 K(+12.5%) |
| Sep 2000 | $134.10 K(+43.9%) | $36.10 K(+28.9%) |
| Jun 2000 | - | $28.00 K(-12.8%) |
| Mar 2000 | - | $32.10 K(-15.3%) |
| Dec 1999 | - | $37.90 K |
| Sep 1999 | $93.20 K(+10.0%) | - |
| Sep 1998 | $84.70 K(-64.0%) | - |
| Sep 1997 | $235.20 K | - |
FAQ
- What is Arrowhead Pharmaceuticals annual total expenses?
- What is the all time high annual total expenses for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals annual total expenses year-on-year change?
- What is Arrowhead Pharmaceuticals quarterly total expenses?
- What is the all time high quarterly total expenses for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals quarterly total expenses year-on-year change?
What is Arrowhead Pharmaceuticals annual total expenses?
The current annual total expenses of ARWR is $604.63 M
What is the all time high annual total expenses for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high annual total expenses is $604.63 M
What is Arrowhead Pharmaceuticals annual total expenses year-on-year change?
Over the past year, ARWR annual total expenses has changed by +$158.89 M (+35.65%)
What is Arrowhead Pharmaceuticals quarterly total expenses?
The current quarterly total expenses of ARWR is $162.20 M
What is the all time high quarterly total expenses for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high quarterly total expenses is $176.14 M
What is Arrowhead Pharmaceuticals quarterly total expenses year-on-year change?
Over the past year, ARWR quarterly total expenses has changed by +$36.01 M (+28.54%)